Ameriprise’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.2M | Sell |
617,094
-56,049
| -8% | -$1.02M | ﹤0.01% | 1720 |
|
|
2025
Q1 | $13.4M | Sell |
673,143
-42,529
| -6% | -$844K | ﹤0.01% | 1563 |
|
|
2024
Q4 | $12.3M | Buy |
715,672
+88,542
| +14% | +$1.52M | ﹤0.01% | 1648 |
|
|
2024
Q3 | $12.5M | Buy |
627,130
+504,357
| +411% | +$10.1M | ﹤0.01% | 1622 |
|
|
2024
Q2 | $1.37M | Sell |
122,773
-96,765
| -44% | -$1.08M | ﹤0.01% | 3024 |
|
|
2024
Q1 | $1.45M | Sell |
219,538
-128,870
| -37% | -$851K | ﹤0.01% | 3020 |
|
|
2023
Q4 | $1.57M | Sell |
348,408
-70,932
| -17% | -$321K | ﹤0.01% | 2992 |
|
|
2023
Q3 | $1.5M | Buy |
419,340
+16,634
| +4% | +$59.6K | ﹤0.01% | 2962 |
|
|
2023
Q2 | $1.49M | Buy |
402,706
+32,844
| +9% | +$121K | ﹤0.01% | 3018 |
|
|
2023
Q1 | $1.22M | Sell |
369,862
-370
| -0.1% | -$1.23K | ﹤0.01% | 3066 |
|
|
2022
Q4 | $1.44M | Sell |
370,232
-3,924
| -1% | -$15.2K | ﹤0.01% | 2955 |
|
|
2022
Q3 | $910K | Sell |
374,156
-11,417
| -3% | -$27.8K | ﹤0.01% | 3155 |
|
|
2022
Q2 | $764K | Buy |
+385,573
| New | +$764K | ﹤0.01% | 3225 |
|
|
2021
Q1 | – | Sell |
-21,400
| Closed | -$44K | – | 3827 |
|
|
2020
Q4 | $44K | Sell |
21,400
-27,280
| -56% | -$56.1K | ﹤0.01% | 3724 |
|
|
2020
Q3 | $116K | Buy |
48,680
+2,270
| +5% | +$5.41K | ﹤0.01% | 3622 |
|
|
2020
Q2 | $136K | Buy |
46,410
+14,110
| +44% | +$41.3K | ﹤0.01% | 3551 |
|
|
2020
Q1 | $93K | Buy |
32,300
+8,700
| +37% | +$25.1K | ﹤0.01% | 3541 |
|
|
2019
Q4 | $94K | Sell |
23,600
-22,405
| -49% | -$89.2K | ﹤0.01% | 3641 |
|
|
2019
Q3 | $205K | Sell |
46,005
-3,395
| -7% | -$15.1K | ﹤0.01% | 3542 |
|
|
2019
Q2 | $191K | Buy |
+49,400
| New | +$191K | ﹤0.01% | 3576 |
|